The pitch deck and business plan were significantly expanded to include the biological mechanisms underlying THCA’s therapeutic rationale. New scientific content addressed PPARγ activation, NF-κB inhibition, inflammatory cytokines, oxidative stress, mitochondrial protection, neuroprotection, and the company’s multi-target platform strategy.